Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Carlomagno

Showing results (11-20 of 46) with videos related to

Pageof 5
Sort By:
Genes, Chromosomes & Cancer|July 9, 1999
Determination of the frequency of the common 657Del5 Nijmegen breakage syndrome mutation in the German population: no association with risk of breast cancerF Carlomagno, J Chang-Claude, A M Dunning, et al.
Journal of Endocrinological Investigation|December 30, 1999
Molecular mechanisms of RET activation in human neoplasiaM Santoro, F Carlomagno, R M Melillo, et al.
Le Infezioni in Medicina|January 1, 1996
[Giardia duodenalis infections in pediatrics: our series]S Scotti, M Pettoello Mantoani, G Polito, et al.
Experimental Cell Research|August 1, 1994
Cloning of the rat tissue inhibitor of metalloproteinases type 2 (TIMP-2) gene: analysis of its expression in normal and transformed thyroid cellsM Santoro, C Battaglia, L Zhang, et al.
Nature Communications|May 21, 2024
Spatiotemporal brain hierarchies of auditory memory recognition and predictive codingL Bonetti, G Fernández-Rubio, F Carlomagno, et al.
Tropical Biomedicine|July 15, 2022
Necrodes littoralis (Coleoptera: Silphidae) visiting and breeding on a carcass in ItalyT Bonacci, F Mendicino, F Carlomagno, et al.
Biochemical and Biophysical Research Communications|February 27, 1995
Point mutation of the RET proto-oncogene in the TT human medullary thyroid carcinoma cell lineF Carlomagno, D Salvatore, M Santoro, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 1998
RET/PTC oncogene activation defines a subset of papillary thyroid carcinomas lacking evidence of progression to poorly differentiated or undifferentiated tumor phenotypesG Tallini, M Santoro, M Helie, et al.
Annales D'Endocrinologie|April 23, 2003
Genetic alterations in differentiated thyroid cancer: what can be expected for gene expression profiling of thyroid carcinomasM Santoro, R M Melillo, F Carlomagno, et al.
Oncogene|April 21, 2001
The insulin receptor substrate (IRS)-1 recruits phosphatidylinositol 3-kinase to Ret: evidence for a competition between Shc and IRS-1 for the binding to RetR M Melillo, F Carlomagno, G De Vita, et al.
Pageof 5

Showing results (11-20 of 46) with videos related to

Sort By:
Pageof 5
Genes, Chromosomes & Cancer|July 9, 1999
Determination of the frequency of the common 657Del5 Nijmegen breakage syndrome mutation in the German population: no association with risk of breast cancerF Carlomagno, J Chang-Claude, A M Dunning, et al.
Journal of Endocrinological Investigation|December 30, 1999
Molecular mechanisms of RET activation in human neoplasiaM Santoro, F Carlomagno, R M Melillo, et al.
Le Infezioni in Medicina|January 1, 1996
[Giardia duodenalis infections in pediatrics: our series]S Scotti, M Pettoello Mantoani, G Polito, et al.
Experimental Cell Research|August 1, 1994
Cloning of the rat tissue inhibitor of metalloproteinases type 2 (TIMP-2) gene: analysis of its expression in normal and transformed thyroid cellsM Santoro, C Battaglia, L Zhang, et al.
Nature Communications|May 21, 2024
Spatiotemporal brain hierarchies of auditory memory recognition and predictive codingL Bonetti, G Fernández-Rubio, F Carlomagno, et al.
Tropical Biomedicine|July 15, 2022
Necrodes littoralis (Coleoptera: Silphidae) visiting and breeding on a carcass in ItalyT Bonacci, F Mendicino, F Carlomagno, et al.
Biochemical and Biophysical Research Communications|February 27, 1995
Point mutation of the RET proto-oncogene in the TT human medullary thyroid carcinoma cell lineF Carlomagno, D Salvatore, M Santoro, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 1998
RET/PTC oncogene activation defines a subset of papillary thyroid carcinomas lacking evidence of progression to poorly differentiated or undifferentiated tumor phenotypesG Tallini, M Santoro, M Helie, et al.
Annales D'Endocrinologie|April 23, 2003
Genetic alterations in differentiated thyroid cancer: what can be expected for gene expression profiling of thyroid carcinomasM Santoro, R M Melillo, F Carlomagno, et al.
Oncogene|April 21, 2001
The insulin receptor substrate (IRS)-1 recruits phosphatidylinositol 3-kinase to Ret: evidence for a competition between Shc and IRS-1 for the binding to RetR M Melillo, F Carlomagno, G De Vita, et al.
Pageof 5